Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease

NCT04330079 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment. (Difficulty in selecting subjects)

Conditions

Coronary Artery Disease
Prediabetic State

Interventions

DRUG: Dapagliflozin 10mg
OTHER: Lifestyle modification

Sponsor

CHEOL WHAN LEE, M.D., Ph.D